Eiken Chemical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3160700005
JPY
2,216.00
31 (1.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

175.7 k

Shareholding (Dec 2016)

FII

0.35%

Held by 1 FIIs

DII

99.65%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a 2.15% CAGR growth in Net Sales over the last 5 years

 
2

Poor long term growth as Net Sales has grown by an annual rate of 2.15% over the last 5 years

 
3

Negative results in Jun 26

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 88,495 Million (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

8.42%

stock-summary
Price to Book

2.01

Revenue and Profits:
Net Sales:
10,728 Million
(Quarterly Results - Jun 2026)
Net Profit:
445 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.82%
0%
-27.82%
6 Months
-10.06%
0%
-10.06%
1 Year
-2.03%
0%
-2.03%
2 Years
4.82%
0%
4.82%
3 Years
52.3%
0%
52.3%
4 Years
18.38%
0%
18.38%
5 Years
0.09%
0%
0.09%

Eiken Chemical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
2.15%
EBIT Growth (5y)
-11.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.84
Tax Ratio
23.27%
Dividend Payout Ratio
51.56%
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
14.52%
ROE (avg)
9.70%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.10
EV to EBIT
28.28
EV to EBITDA
15.68
EV to Capital Employed
2.18
EV to Sales
2.15
PEG Ratio
0.21
Dividend Yield
NA
ROCE (Latest)
7.70%
ROE (Latest)
9.33%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2016stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.35%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 1.96% vs -3.88% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 3,278.57% vs -101.88% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,728.00",
          "val2": "10,522.00",
          "chgp": "1.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,274.00",
          "val2": "846.00",
          "chgp": "50.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.00",
          "val2": "15.00",
          "chgp": "26.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "445.00",
          "val2": "-14.00",
          "chgp": "3,278.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "62.30%",
          "val2": "13.40%",
          "chgp": "4.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 3.35% vs 1.22% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 66.43% vs -15.41% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "41,899.00",
          "val2": "40,539.00",
          "chgp": "3.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,457.00",
          "val2": "5,554.00",
          "chgp": "-1.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29.00",
          "val2": "17.00",
          "chgp": "70.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-250.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,708.00",
          "val2": "2,228.00",
          "chgp": "66.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "69.70%",
          "val2": "74.00%",
          "chgp": "-0.43%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
10,728.00
10,522.00
1.96%
Operating Profit (PBDIT) excl Other Income
1,274.00
846.00
50.59%
Interest
19.00
15.00
26.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
445.00
-14.00
3,278.57%
Operating Profit Margin (Excl OI)
62.30%
13.40%
4.89%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 1.96% vs -3.88% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 3,278.57% vs -101.88% in Mar 2026

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
41,899.00
40,539.00
3.35%
Operating Profit (PBDIT) excl Other Income
5,457.00
5,554.00
-1.75%
Interest
29.00
17.00
70.59%
Exceptional Items
0.00
-250.00
100.00%
Consolidate Net Profit
3,708.00
2,228.00
66.43%
Operating Profit Margin (Excl OI)
69.70%
74.00%
-0.43%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 3.35% vs 1.22% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 66.43% vs -15.41% in Mar 2025

stock-summaryCompany CV
About Eiken Chemical Co., Ltd. stock-summary
stock-summary
Eiken Chemical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available